In the case we describe, due to the patient presenting with AKI KDIGO 3 and hemodynamic instability, CRRT was initially utilized in the CVVHDF modality, taking advantage of the solute removal characteristics that this modality offers to reduce elevated serum myoglobin levels. This evidence concerns the gene MB and acute kidney injury.